Thermo Fisher Scientific (TMO) DIvidends Date & History

Key Takeaways

• Thermo Fisher Scientific (TMO) pays a modest quarterly dividend of $0.47 per share, or about $1.88 per share annually.
• At current prices, the dividend yield is roughly 0.3%, well below the healthcare sector average of around 1.4%.
• The dividend payout ratio is only about 10% of earnings, leaving substantial room for future increases.
• The company has raised its dividend for eight consecutive years, with a five-year compound annual growth rate near 14%.
• TMO is better suited to dividend growth and long-term investors than to investors seeking immediate income.

Dividend Overview

Thermo Fisher Scientific is a leading global provider of life sciences tools, analytical instruments, diagnostics, and pharmaceutical research services. The company pays a quarterly cash dividend, currently $0.47 per share, which works out to about $1.88 per share on an annualized basis. Based on recent share prices, that translates to a dividend yield of approximately 0.3% — a level that places the stock firmly in the low-yield category rather than among income-oriented holdings.

Thermo Fisher is best described as a dividend growth stock with a modest starting yield. The company prioritizes reinvesting cash into acquisitions and research and development while returning a smaller, steadily rising portion of earnings to shareholders. Payments are made quarterly, typically in March, June, September, and December, which provides a consistent, predictable cadence for investors who hold the stock over the long term.

Dividend History and Growth

Thermo Fisher Scientific initiated its dividend in 2012 and has increased the payout every year since, building a track record of eight consecutive years of dividend increases. The most recent quarterly payment rose to $0.47 per share, up from $0.43 a year earlier and $0.39 in 2024. Over the past five years, the dividend has grown at a compound annual rate of roughly 14%, a pace that significantly outpaces the typical dividend grower in the broader market.

This growth reflects Thermo Fisher's durable earnings power and disciplined capital allocation. Rather than prioritizing a high current yield, management has used its strong cash generation to fund both shareholder returns and strategic investments across its life sciences and pharma services businesses. The result is a payout that is small relative to profits but compounding rapidly over time.

Dividend Sustainability and Payout Ratio

Thermo Fisher's dividend appears highly sustainable by virtually any measure. The company pays out only about 10% of its trailing earnings as dividends, and roughly 6% of its operating cash flow, according to recent filings. These figures are far below the levels at which dividend safety typically becomes a concern, giving the company a wide margin to maintain and grow the payout even if earnings were to moderate.

Thermo Fisher also maintains a strong balance sheet and consistent free cash flow generation, supported by its diversified product portfolio and recurring revenue streams in consumables and services. This financial stability reduces the risk of a dividend cut and provides ample capacity for the company to continue its streak of annual increases alongside its share buyback program.

Dividend Compared to Industry Peers

Relative to its healthcare and life sciences peers, Thermo Fisher's dividend yield is on the lower end of the spectrum. The healthcare sector average yield sits around 1.4%, and many established medical-device and diagnostic companies pay meaningfully more. For example, diversified healthcare peer ABT (Abbott Laboratories) offers a higher yield, while life-sciences counterpart DHR (Danaher) maintains a similarly low-yield, growth-oriented profile.

What Thermo Fisher lacks in current yield, however, it partly compensates for through a faster dividend growth rate. Investors comparing TMO to peers should weigh the modest yield against the company's rapid payout increases and exceptionally low payout ratio, which suggest the dividend can keep compounding for years to come.

AI Screener

Tickeron's AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener can help identify dividend stocks, income-focused investments, trending stocks, breakout candidates, and other market opportunities more efficiently than manual screening. Explore the AI Screener to build a watchlist tailored to your own investing criteria.

Is This Stock Attractive for Dividend Investors?

Thermo Fisher Scientific is most appropriate for dividend growth investors and long-term, total-return-focused shareholders rather than investors who depend on current income. With a yield near 0.3%, the stock will not meaningfully supplement an investor's cash flow today. However, its very low payout ratio and consistent history of double-digit-percentage dividend increases make it an appealing candidate for those willing to let the payout compound over a multi-year holding period.

Investors focused on yield alone will likely find better income alternatives elsewhere in the healthcare sector. Conservative investors who value balance-sheet strength and dividend safety may appreciate Thermo Fisher's minimal risk of a cut, while growth-oriented investors can benefit from the company's reinvestment in high-growth areas such as bioproduction and pharmaceutical services. As always, whether the stock fits a given portfolio depends on an individual investor's objectives, time horizon, and risk tolerance.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations